Journal article

Optimal approach for high-risk acute promyelocytic leukemia

Harry J Iland, John F Seymour, Andrew Wei

Current Opinion in Hematology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2014

DOI: 10.1097/MOH.0000000000000025

Citation metrics

7Web of Science
9Scopus

Keywords

Early Death
Humans
Induction Chemotherapy
Acute Promyelocytic Leukemia
Neoplasm Recurrence, Local
Arsenic Trioxide
Science & Technology
All-Trans Retinoic Acid
Leukemia, Promyelocytic, Acute
Acute Myeloid-Leukemia
Elderly-Patients
Life Sciences & Biomedicine
Flt3 Mutation Status
Complete Remission
Relapse
Early Death Rate
Risk Factors
Maintenance Chemotherapy
Trans-Retinoic Acid
Risk Stratification
Additional Chromosome-Abnormalities
Treatment Failure
Risk-Adapted Therapy
Antineoplastic Combined Chemotherapy Protocols
Treatment Outcome
Hematology
Anthracycline Monochemotherapy
Receptor-Alpha
Consolidation Chemotherapy